Donepezil treatment of topiramate-related cognitive dysfunction.
Six migraine patients experienced significant topiramate-related cognitive and language dysfunction that improved with donepezil treatment and allowed uninterrupted topiramate use. These patients represent the first report of topiramate-related cognitive and language dysfunction that improved with a cholinesterase inhibitor. Although, the mechanism responsible for this effect is uncertain, cholinesterase inhibition resulting in cholinergic augmentation and enhanced cognition probably account for some if not most of the improvement.
Wheeler
Steve D
SD
Ryan Wheeler Headache Treatment Center, Miami, FL 33189, USA.
D000328:Adult; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D003072:Cognition Disorders / Q000139:chemically induced / Q000188:drug therapy*; D000077265:Donepezil; D005260:Female; D005632:Fructose / Q000009:adverse effects / Q000031:analogs & derivatives*; D006801:Humans; D007189:Indans / Q000627:therapeutic use*; D007806:Language Disorders / Q000139:chemically induced / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D008881:Migraine Disorders / Q000188:drug therapy; D010880:Piperidines / Q000627:therapeutic use*; D000077236:Topiramate; D016896:Treatment Outcome
D002800:Cholinesterase Inhibitors; D007189:Indans; D010880:Piperidines; D000077236:Topiramate; D005632:Fructose; D000077265:Donepezil